A Novel Approach to Essential Thrombocythemia and Cardiac Surgery.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28219560.
- Also identified by DOI 10.1016/j.athoracsur.2016.08.065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by persistent thrombocytosis (>450 × 10<sup>9</sup>/L). Patients with ET are at risk for thrombotic or hemorrhagic complications especially during cardiovascular operations. We discuss a patient with ET requiring coronary artery bypass grafting with a presenting platelet count of 1631 × 10<sup>9</sup>/L. Platelet reduction with an intraoperative autologous transfusion technique decreased the platelet count to 758 × 10<sup>9</sup>/L before initiation of cardiopulmonary bypass. In addition, perioperative cangrelor therapy was administered to further limit risk of thrombotic complications. The patient had an uneventful perioperative and postoperative course.
Medical subject headings
- Coronary Artery Bypass
- Thrombocythemia, Essential
- Thrombosis